Researchers at the Weizmann Institute of Science, in collaboration with physicians, have conducted a study in mice, in which they used existing drugs in a new combination to help crush potential resistance to treatment.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
New research presented this week at the Alzheimer’s Association International Conference (AAIC) 2018, is suggesting that the liver could be contributing to Alzheimer’s risk by failing to supply key lipids to the brain.
Researchers have found a genetic material related to the Ebola Virus in mouse-eared bats thats remained largely unchanged for over 18 million years. The study sheds light on the gene’s possible function in bats, suggesting that it may play a role in regulating the immune system’s response to threats.
By identifying and characterizing specific types of mutations in individual cell lines, using a combination of whole genome sequencing and multi-omic approaches, researchers hope to improve stem cells’ therapeutic uses and potential.
Elementary cytoskeleton protein is different in parasites and represents a starting point for a possible new therapy against malaria infections.
The strengths of blockchain technologies could help address the weaknesses of health care systems to store and secure medical records.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics: